Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
The Lymphoma Academic Research Organisation
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
University Hospital, Tours
Institute of Hematology & Blood Diseases Hospital, China
H. Lee Moffitt Cancer Center and Research Institute
Centre Henri Becquerel
Institut Claudius Regaud
Massachusetts General Hospital
M.D. Anderson Cancer Center
Baylor College of Medicine
Centre Antoine Lacassagne
IRCCS San Raffaele
Hospices Civils de Lyon
Institut Bergonié
Universität des Saarlandes
Insel Gruppe AG, University Hospital Bern
Second Affiliated Hospital, School of Medicine, Zhejiang University
International Extranodal Lymphoma Study Group (IELSG)
Northwestern University
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Emory University
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Charles University, Czech Republic
Mayo Clinic
Charite University, Berlin, Germany
Medical University of South Carolina
Vanderbilt-Ingram Cancer Center
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Calibr, a division of Scripps Research
Ruijin Hospital
City of Hope Medical Center
Case Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
IRCCS San Raffaele
City of Hope Medical Center
Herlev Hospital
University Hospital Southampton NHS Foundation Trust
University Hospital Muenster
University of Nebraska